Table of Contents Table of Contents
Previous Page  2356-2357 / 2437 Next Page
Information
Show Menu
Previous Page 2356-2357 / 2437 Next Page
Page Background

Dexamethasone dosing

• 96 patients; 2 randomized, double-blind trials

• Dexamethasone: 4 vs. 16 mg/d

8 vs. 16 mg/d

Primary endpoint: KPS => no difference

• Side effects: more frequent in patients taking 16 mg/d

Vecht et al., Neurology 1994